Half-year report · Q2

Period2025-01-01 → 2025-06-30
Filed2025-08-12
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 42
MetricValuePeriodScopeSource row
Revenue¥252m2025-01-01 → 2025-06-30StandaloneNet sales
Revenue¥781m2024-01-01 → 2024-12-31StandaloneNet sales (5-year summary)
Revenue¥264m2024-01-01 → 2024-06-30StandaloneNet sales
Operating income−¥537m2025-01-01 → 2025-06-30StandaloneOperating income
Operating income−¥581m2024-01-01 → 2024-06-30StandaloneOperating income
Ordinary income−¥539m2025-01-01 → 2025-06-30StandaloneOrdinary income
Ordinary income−¥1.0bn2024-01-01 → 2024-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥563m2024-01-01 → 2024-06-30StandaloneOrdinary income
Profit before tax−¥539m2025-01-01 → 2025-06-30StandaloneIncome before income taxes
Profit before tax−¥562m2024-01-01 → 2024-06-30StandaloneIncome before income taxes
Net income−¥540m2025-01-01 → 2025-06-30StandaloneProfit loss
Net income−¥1.0bn2024-01-01 → 2024-12-31StandaloneNet income loss (5-year summary)
Net income−¥564m2024-01-01 → 2024-06-30StandaloneProfit loss
Total assets¥2.0bnat 2025-06-30StandaloneAssets
Total assets¥2.5bnat 2024-12-31StandaloneAssets
Total assets¥1.6bnat 2024-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥443mat 2025-06-30StandaloneLiabilities
Total liabilities¥549mat 2024-12-31StandaloneLiabilities
Net assets / equity¥1.5bnat 2025-06-30StandaloneNet assets
Net assets / equity¥1.9bnat 2024-12-31StandaloneNet assets
Net assets / equity¥1.1bnat 2024-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.5bnat 2025-06-30StandaloneCash and deposits
Cash and deposits¥2.1bnat 2024-12-31StandaloneCash and deposits
Cash & equivalents¥1.5bnat 2025-06-30StandaloneCash and cash equivalents
Cash & equivalents¥2.1bnat 2024-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2024-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.3bnat 2023-12-31vStandaloneCash and cash equivalents
Operating cash flow−¥673m2025-01-01 → 2025-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.0bn2024-01-01 → 2024-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥677m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in operating activities
Financing cash flow¥85m2025-01-01 → 2025-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.7bn2024-01-01 → 2024-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥455m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-7.972025-01-01 → 2025-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-17.542024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-10.212024-01-01 → 2024-06-30StandaloneBasic earnings loss per share (5-year summary)
Equity ratio76.9%at 2025-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.4%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio68.0%at 2024-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued68,053,800at 2025-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued66,969,000at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued56,387,000at 2024-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 16
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30−¥280m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2025-01-01 → 2025-06-30−¥396m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue2025-01-01 → 2025-06-30¥252m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue external2025-01-01 → 2025-06-30¥252m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentsegment profit2025-01-01 → 2025-06-30¥139m
Total Of Reportable Segments And Otherssegment totalrevenue2025-01-01 → 2025-06-30¥252m
Total Of Reportable Segments And Otherssegment totalrevenue external2025-01-01 → 2025-06-30¥252m
Total Of Reportable Segments And Otherssegment totalsegment profit2025-01-01 → 2025-06-30−¥257m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30−¥269m
jpcrp040300-q2r_E26096-000Drug Discovery And Developmentreportable segmentsegment profit2024-01-01 → 2024-06-30−¥447m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue2024-01-01 → 2024-06-30¥264m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentrevenue external2024-01-01 → 2024-06-30¥264m
jpcrp040300-q2r_E26096-000Drug Discovery Supportreportable segmentsegment profit2024-01-01 → 2024-06-30¥135m
Total Of Reportable Segments And Otherssegment totalrevenue2024-01-01 → 2024-06-30¥264m
Total Of Reportable Segments And Otherssegment totalrevenue external2024-01-01 → 2024-06-30¥264m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-01-01 → 2024-06-30−¥312m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 427
ItemContextValueUnit
Accounts receivable tradeCurrentQuarterInstant_NonConsolidatedMember39373000JPY
InventoriesPrior1YearInstant_NonConsolidatedMember46171000JPY
InventoriesCurrentQuarterInstant_NonConsolidatedMember46666000JPY
Advance payments tradePrior1YearInstant_NonConsolidatedMember101992000JPY
Advance payments tradeCurrentQuarterInstant_NonConsolidatedMember104242000JPY
Consumption taxes receivablePrior1YearInstant_NonConsolidatedMember24425000JPY
Consumption taxes receivableCurrentQuarterInstant_NonConsolidatedMember16090000JPY
Other caPrior1YearInstant_NonConsolidatedMember50738000JPY
Other caCurrentQuarterInstant_NonConsolidatedMember149161000JPY
Current assetsPrior1YearInstant_NonConsolidatedMember2337672000JPY
Current assetsCurrentQuarterInstant_NonConsolidatedMember1830487000JPY
Machinery and equipmentPrior1YearInstant_NonConsolidatedMember230491000JPY
Machinery and equipmentCurrentQuarterInstant_NonConsolidatedMember222675000JPY
Accumulated depreciation machinery and equipmentPrior1YearInstant_NonConsolidatedMember-230491000JPY
Accumulated depreciation machinery and equipmentCurrentQuarterInstant_NonConsolidatedMember-222675000JPY
Machinery and equipment netPrior1YearInstant_NonConsolidatedMember0JPY
Machinery and equipment netCurrentQuarterInstant_NonConsolidatedMember0JPY
Tools furniture and fixturesPrior1YearInstant_NonConsolidatedMember82364000JPY
Tools furniture and fixturesCurrentQuarterInstant_NonConsolidatedMember82364000JPY
Accumulated depreciation tools furniture and fixturesPrior1YearInstant_NonConsolidatedMember-82364000JPY
Accumulated depreciation tools furniture and fixturesCurrentQuarterInstant_NonConsolidatedMember-82364000JPY
Tools furniture and fixtures netPrior1YearInstant_NonConsolidatedMember0JPY
Tools furniture and fixtures netCurrentQuarterInstant_NonConsolidatedMember0JPY
Property plant and equipmentPrior1YearInstant_NonConsolidatedMember0JPY
Property plant and equipmentCurrentQuarterInstant_NonConsolidatedMember0JPY
Long term prepaid expensesPrior1YearInstant_NonConsolidatedMember18375000JPY
Long term prepaid expensesCurrentQuarterInstant_NonConsolidatedMember19429000JPY
Lease and guarantee depositsPrior1YearInstant_NonConsolidatedMember112809000JPY
Lease and guarantee depositsCurrentQuarterInstant_NonConsolidatedMember112808000JPY
Other ioaPrior1YearInstant_NonConsolidatedMember0JPY
Other ioaCurrentQuarterInstant_NonConsolidatedMember0JPY
Investments and other assetsPrior1YearInstant_NonConsolidatedMember131184000JPY
Investments and other assetsCurrentQuarterInstant_NonConsolidatedMember132237000JPY
Noncurrent assetsPrior1YearInstant_NonConsolidatedMember131185000JPY
Noncurrent assetsCurrentQuarterInstant_NonConsolidatedMember132238000JPY
AssetsPrior1YearInstant_NonConsolidatedMember2468857000JPY
AssetsCurrentQuarterInstant_NonConsolidatedMember1962725000JPY
Accounts payable tradePrior1YearInstant_NonConsolidatedMember27196000JPY
Accounts payable tradeCurrentQuarterInstant_NonConsolidatedMember36828000JPY
Short term loans payablePrior1YearInstant_NonConsolidatedMember281500000JPY
Short term loans payableCurrentQuarterInstant_NonConsolidatedMember260500000JPY
Accounts payable otherPrior1YearInstant_NonConsolidatedMember138103000JPY
Accounts payable otherCurrentQuarterInstant_NonConsolidatedMember62871000JPY
Accrued expensesPrior1YearInstant_NonConsolidatedMember29557000JPY
Accrued expensesCurrentQuarterInstant_NonConsolidatedMember11432000JPY
Income taxes payablePrior1YearInstant_NonConsolidatedMember2531000JPY
Income taxes payableCurrentQuarterInstant_NonConsolidatedMember10327000JPY
Deposits receivedPrior1YearInstant_NonConsolidatedMember14543000JPY
Deposits receivedCurrentQuarterInstant_NonConsolidatedMember6096000JPY
Current liabilitiesPrior1YearInstant_NonConsolidatedMember493432000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2024-12-31pass rounding
balance sheet identitynon_consolidated 2025-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net assetsnon_consolidated 2025-06-30pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flownon_consolidated 2025-01-01/2025-06-30pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · revenuenon_consolidated 2025-01-01/2025-06-30pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2025-06-30pass